NONCOVALENT BINDING OF A MITOMYCIN-C METABOLITE, 2,7-DIAMINOMITOSENE, TO DUPLEX DNA

被引：6
|
作者：
PETERSON, DM
FISHER, J
BEALL, HD
ROSS, D
机构：
[1] UNIV COLORADO, HLTH SCI CTR, SCH PHARM, DENVER, CO 80262 USA
[2] UNIV COLORADO, HLTH SCI CTR, CTR CANC, DENVER, CO 80262 USA
来源：
CANCER LETTERS | 1995年 / 90卷 / 02期
关键词：
MITOMYCIN C; 2,7-DIAMINOMITOSENE (DAM); BIOREDUCTIVE ACTIVATION; INTERCALATION; NONCOVALENT INTERACTION WITH DNA; DT-DIAPHORASE;
D O I：
10.1016/0304-3835(95)03694-R
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The major metabolite of mitomycin C, 2,7-diaminomitosene (DAM), interacts noncovalently with DNA. This was supported by ultraviolet-visible spectrum changes upon mixing with DNA and ethidium bromide displacement from DNA, measured as fluorescence changes. Moreover, DAM bound to DNA sufficiently strongly to hold DNA in a double stranded conformation under denaturing gel electrophoresis conditions commonly used to measure mitomycin C cross-links. These data show that generation of DAM and interaction with DNA represent a potential additional mechanism of DNA damage induced by mitomycin C.
引用
收藏
页码：133 / 138
页数：6
相关论文
共 50 条
  • [1] BINDING OF 2,7-DIAMINOMITOSENE TO DNA - MODEL FOR THE PRECOVALENT RECOGNITION OF DNA BY ACTIVATED MITOMYCIN-C
    KUMAR, GS
    HE, QY
    BEHRVENTURA, D
    TOMASZ, M
    BIOCHEMISTRY, 1995, 34 (08) : 2662 - 2671
  • [2] CONVERSION OF MITOMYCIN-C TO 2,7-DIAMINOMITOSENE AND 10-DECARBAMOYL 2,7-DIAMINOMITOSENE IN TUMOR-TISSUE IN-VIVO
    CHIRREY, L
    CUMMINGS, J
    HALBERT, GW
    SMYTH, JF
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (04) : 318 - 322
  • [3] DNA adduct of the mitomycin C metabolite 2,7-diaminomitosene is a nontoxic and nonmutagenic DNA lesion in vitro and in vivo
    Utzat, CD
    Clement, CC
    Ramos, LA
    Das, A
    Tomasz, M
    Basu, AK
    CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (02) : 213 - 223
  • [4] ALKYLATION OF DNA BY C-10 OF 2,7-DIAMINOMITOSENE
    IYENGAR, BS
    DORR, RT
    SHIPP, NG
    REMERS, WA
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (01) : 253 - 257
  • [5] Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C
    Palom, Y
    Belcourt, MF
    Kumar, GS
    Arai, H
    Kasai, M
    Sartorelli, AC
    Rockwell, S
    Tomasz, M
    ONCOLOGY RESEARCH, 1998, 10 (10) : 509 - 521
  • [6] NUCLEOTIDE DERIVATIVES OF 2,7-DIAMINOMITOSENE
    IYENGAR, BS
    DORR, RT
    REMERS, WA
    KOWAL, CD
    JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (08) : 1579 - 1585
  • [7] Solution structure of a guanine-N7-linked complex of the mitomycin C metabolite 2,7-diaminomitosene and DNA. Basis of sequence selectivity
    Subramaniam, G
    Paz, MM
    Kumar, GS
    Das, A
    Palom, Y
    Clement, CC
    Patel, DJ
    Tomasz, M
    BIOCHEMISTRY, 2001, 40 (35) : 10473 - 10484
  • [8] DETERMINATION OF MITOMYCIN-C, 2,7-DIAMINOMITOSENE, 1,2-CIS-1-HYDROXY-2 AND 1,2-TRANS-1-HYDROXY-2,7-DIAMINOMITOSENE IN TUMOR-TISSUE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    CUMMINGS, J
    CHIRREY, L
    WILLMOTT, N
    HALBERT, GW
    SMYTH, JF
    JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 612 (01): : 105 - 113
  • [9] Comparison of translesion bypass of guanine-N2 monoadducts of mitomycin C and guanine-N7 monoadducts of 2,7-diaminomitosene by DNA polymerases
    Clement, CC
    Tomasz, M
    FASEB JOURNAL, 2003, 17 (04): : A600 - A600
  • [10] Comparison of translesion bypass of guanine-N2 monoadducts of mitomycin C and guanine-N7 monoadducts of 2,7-diaminomitosene by DNA polymerases.
    Clement, CC
    Tomasz, M
    CHEMICAL RESEARCH IN TOXICOLOGY, 2003, 16 (12) : 1667 - 1667
12345